Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05695885 · ClinicalTrials.gov registry record · NA

STEPS Implementation Trial

A NA study of Autism Spectrum Disorder, sponsored by University of Alabama, Tuscaloo.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05695885 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by University of Alabama, Tuscaloo. The registered enrollment target is 80 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05695885, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by University of Alabama, Tuscaloo.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This study will inform understanding of how to support emerging adults with autism spectrum disorder (ASD). The investigators will use a theoretically informed and research-based transition support program developed for people with ASD and test how effective it is when delivered by community agencies. Results will provide information on the effectiveness of the program as well as on mechanisms of change and contextual factors that promote or impede implementation.

Conditions Studied

Interventions

  • BEHAVIORAL STEPS
  • BEHAVIORAL Services as usual (SAU)

Study Locations (1)

Alabama

  • Center o=for Youth Development and Intervention - Tuscaloosa

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-04-01
Est. Completion 2025-12-31
Phase NA

Sponsor

University of Alabama, Tuscaloo

17 total trials

What the Registry Record Tells You About NCT05695885

The ClinicalTrials.gov registry entry for NCT05695885 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (41% lower). The listed sponsor is University of Alabama, Tuscaloo, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which STEPS is the first listed.

NCT05695885 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05695885 about?

NCT05695885 is a clinical study titled "STEPS Implementation Trial". This study will inform understanding of how to support emerging adults with autism spectrum disorder (ASD). The investigators will use a theoretically informed and research-based transition support program developed for people with ASD and test how effective it is when delivered by community agencie...

What is the current status of trial NCT05695885?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-04-01. Estimated completion is 2025-12-31.

What conditions does trial NCT05695885 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT05695885?

The interventions under investigation include: STEPS (BEHAVIORAL), Services as usual (SAU) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05695885?

This trial is sponsored by University of Alabama, Tuscaloo, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05695885 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.